Mackels, L.; Mariot, V.; Buscemi, L.; Servais, L.; Dumonceaux, J.
Impact of Disease Severity and Disease-Modifying Therapies on Myostatin Levels in SMA Patients. Int. J. Mol. Sci. 2024, 25, 8763.
https://doi.org/10.3390/ijms25168763
AMA Style
Mackels L, Mariot V, Buscemi L, Servais L, Dumonceaux J.
Impact of Disease Severity and Disease-Modifying Therapies on Myostatin Levels in SMA Patients. International Journal of Molecular Sciences. 2024; 25(16):8763.
https://doi.org/10.3390/ijms25168763
Chicago/Turabian Style
Mackels, Laurane, Virginie Mariot, Laura Buscemi, Laurent Servais, and Julie Dumonceaux.
2024. "Impact of Disease Severity and Disease-Modifying Therapies on Myostatin Levels in SMA Patients" International Journal of Molecular Sciences 25, no. 16: 8763.
https://doi.org/10.3390/ijms25168763
APA Style
Mackels, L., Mariot, V., Buscemi, L., Servais, L., & Dumonceaux, J.
(2024). Impact of Disease Severity and Disease-Modifying Therapies on Myostatin Levels in SMA Patients. International Journal of Molecular Sciences, 25(16), 8763.
https://doi.org/10.3390/ijms25168763